Stem Cell Research
Recipients of grants from the California Institute of Regenerative Medicine would be required to contract for goods and services from California companies when possible under AB 2381 by Assembly member Gene Mullin (D-San Mateo) (Bill text, 3/10). The measure is before the Senate Rules Committee (Bill status, 3/6).
This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.